These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2322987

  • 1. Triple combination of retinoic acid plus actinomycin D plus dimethylformamide induces differentiation of human acute myeloid leukaemic blasts in primary culture.
    Hassan HT, Rees J.
    Cancer Chemother Pharmacol; 1990; 26(1):26-30. PubMed ID: 2322987
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Triple combination of retinoic acid + low concentration of cytosine arabinoside + hexamethylene bisacetamide induces differentiation of human AML blasts in primary culture.
    Hassan HT, Rees JK.
    Hematol Oncol; 1989; 7(6):429-40. PubMed ID: 2807181
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. New synergistic combinations of differentiation inducing agents in the treatment of acute myeloid leukaemia.
    Hassan HT, Zyada LE, Ragab MH, Rees JK.
    Eur J Clin Pharmacol; 1991; 41(6):531-6. PubMed ID: 1815964
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia.
    Redner RL, Beumer JH, Kropf P, Agha M, Boyiadzis M, Dorritie K, Farah R, Hou JZ, Im A, Lim SH, Raptis A, Sehgal A, Christner SM, Normolle D, Johnson DE.
    Leuk Lymphoma; 2018 Nov; 59(11):2595-2601. PubMed ID: 29616864
    [Abstract] [Full Text] [Related]

  • 11. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
    Breitman TR, He RY.
    Cancer Res; 1990 Oct 01; 50(19):6268-73. PubMed ID: 2400989
    [Abstract] [Full Text] [Related]

  • 12. Recombinant human interleukin-6 enhances the antiproliferation and differentiation inducing effects of retinoic acid in HL-60 human myeloid leukaemic cells.
    Hassan HT.
    Clin Exp Pharmacol Physiol; 1991 Dec 01; 18(12):847-51. PubMed ID: 1797449
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.
    Breitman TR, Selonick SE, Collins SJ.
    Proc Natl Acad Sci U S A; 1980 May 01; 77(5):2936-40. PubMed ID: 6930676
    [Abstract] [Full Text] [Related]

  • 15. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor.
    Altucci L, Rossin A, Hirsch O, Nebbioso A, Vitoux D, Wilhelm E, Guidez F, De Simone M, Schiavone EM, Grimwade D, Zelent A, de Thé H, Gronemeyer H.
    Cancer Res; 2005 Oct 01; 65(19):8754-65. PubMed ID: 16204045
    [Abstract] [Full Text] [Related]

  • 16. Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia.
    Kuendgen A, Knipp S, Fox F, Strupp C, Hildebrandt B, Steidl C, Germing U, Haas R, Gattermann N.
    Ann Hematol; 2005 Dec 01; 84 Suppl 1():61-6. PubMed ID: 16270213
    [Abstract] [Full Text] [Related]

  • 17. The differentiating effect of retinoic acid and vincristine on acute myeloid leukemia.
    Leung MF, Wong KF.
    J Hematother; 1999 Jun 01; 8(3):275-9. PubMed ID: 10417051
    [Abstract] [Full Text] [Related]

  • 18. Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2.
    Britschgi A, Simon HU, Tobler A, Fey MF, Tschan MP.
    Br J Haematol; 2010 Apr 01; 149(1):55-64. PubMed ID: 20096012
    [Abstract] [Full Text] [Related]

  • 19. Potentiation between intracellular cyclic-AMP-elevating agents and inducers of leukemic cell differentiation.
    Fontana J, Munoz M, Durham J.
    Leuk Res; 1985 Apr 01; 9(9):1127-32. PubMed ID: 2415782
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the antiproliferative effects of transforming growth factor-beta, N,N-dimethylformamide and retinoic acid on a human colon carcinoma cell line.
    Hoosein NM, Brattain DE, McKnight MK, Childress KE, Chakrabarty S, Brattain MG.
    Cancer Lett; 1988 Jun 15; 40(2):219-32. PubMed ID: 3164250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.